GPGI, Inc. has released its financial results for the third quarter of 2026, revealing key insights into its operations and future plans. The company also declared a quarterly cash dividend, reflecting its strategy to enhance shareholder value.
Company Overview
GPGI, Inc. operates within the finance services sector, classified under SIC 6199. The company is listed on the New York Stock Exchange under the ticker symbol GPGI. GPGI has undergone several name changes in recent years, previously known as CompoSecure, Inc. and Roman DBDR Tech Acquisition Corp.
What the Filing Says
According to the recent SEC filing dated November 5, 2026, GPGI reported its financial results for the three and nine months ending September 30, 2026. The filing also included a press release and an investor presentation, which are available as Exhibits 99.1 and 99.2.
In the filing, the company stated, "The Company’s board of directors has declared a quarterly cash dividend in the amount of $0.0025 per share of Class A common stock of the Company, payable on December 1, 2026, to all holders of record as of November 18, 2026." This announcement underscores GPGI's commitment to returning capital to its shareholders.
Impact
The financial results and dividend declaration may affect various stakeholders, including shareholders, potential investors, and financial analysts monitoring the finance services sector. The announcement signals GPGI's ongoing strategy to maintain a competitive edge and provide value to its shareholders amidst fluctuating market conditions.
What's Next
Following this filing, GPGI is expected to continue its engagement with investors and analysts, providing further insights into its operational strategies and market positioning. The filing does not specify any upcoming votes or additional actions.
Read Next
Ronald N. Tutor sells 150,000 shares of Tutor Perini Corp.
Generation Income Properties reports Q3 2026 results
Greenlane Holdings reports Q3 2026 results amid challenges
Permianville Royalty Trust Reports Q3 Financial Results
Cue Biopharma Reports Q3 Results with Financial Insights
Atlantica Inc Reports Q3 Results, Highlights Financial Updates










